Go Pro
NYSE:USNA

USANA Health Sciences (USNA) Stock Price, News & Analysis

USANA Health Sciences logo
$14.35 -0.36 (-2.45%)
Closing price 09/17/2026 03:59 PM Eastern
Extended Trading
$14.34 -0.01 (-0.07%)
As of 07:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About USANA Health Sciences Stock (NYSE:USNA)

Advanced

Key Stats

Today's Range
$14.31
$15.00
50-Day Range
$12.79
$23.22
52-Week Range
$12.57
$30.92
Volume
164,377 shs
Average Volume
200,313 shs
Market Capitalization
$265.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

USANA Health Sciences, Inc. develops and sells nutritional supplements, healthy foods and personal-care products. Its offerings include vitamin and mineral supplements, meal-replacement products, protein and nutrition products, and skincare and personal-care items marketed under the USANA brand.

Founded in 1992 by immunologist Myron Wentz, the company uses a direct-selling business model. Products are distributed through independent associates, who market and sell USANA offerings directly to consumers and may build networks of other distributors. The company also provides products through its online shopping platforms in markets where it operates.

USANA serves customers across a range of markets in the Asia-Pacific region, the Americas and Europe. Its products are manufactured and distributed in accordance with applicable regulatory requirements in the jurisdictions where they are sold, with the company emphasizing health, wellness and personal-care solutions.

AI Generated. May Contain Errors.

USANA Health Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

USNA MarketRank™: 

USANA Health Sciences scored higher than 33% of companies evaluated by MarketBeat, and ranked 138th out of 174 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    USANA Health Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    USANA Health Sciences has only been the subject of 2 research reports in the past 90 days.

  • Read more about USANA Health Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for USANA Health Sciences are expected to grow by 132.89% in the coming year, from $0.76 to $1.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of USANA Health Sciences is -11.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of USANA Health Sciences is -11.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    USANA Health Sciences has a PEG Ratio of 1.61. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    USANA Health Sciences has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about USANA Health Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    3.52% of the float of USANA Health Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    USANA Health Sciences has a short interest ratio ("days to cover") of 3.13, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in USANA Health Sciences has recently decreased by 14.59%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    USANA Health Sciences does not currently pay a dividend.

  • Dividend Growth

    USANA Health Sciences does not have a long track record of dividend growth.

  • Search Interest

    1 people have searched for USNA on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, USANA Health Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.82% of the stock of USANA Health Sciences is held by insiders.

  • Percentage Held by Institutions

    54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about USANA Health Sciences' insider trading history.
Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

USNA Stock News Headlines

The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.tc pixel
USANA Health Sciences : USNA
USANA Health Sciences Trims Outlook Amid Brand Headwinds
See More Headlines

USNA Stock Analysis - Frequently Asked Questions

USANA Health Sciences' stock was trading at $19.61 at the beginning of 2026. Since then, USNA shares have decreased by 26.8% and is now trading at $14.35.

USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by $0.50. The firm earned $223.27 million during the quarter, compared to the consensus estimate of $235 million. USANA Health Sciences had a positive trailing twelve-month return on equity of 3.41% and a negative net margin of 2.43%.
Read the conference call transcript
.

Top institutional shareholders of USANA Health Sciences include BlackRock Inc. (8.42%), Pzena Investment Management LLC (6.53%), Nantahala Capital Management LLC (4.39%) and Algert Global LLC (0.71%). Insiders that own company stock include Myron W Wentz, Jim Brown, Kevin Guest, David Mulham Mulham, Frederic J Winssinger, John Turman Fleming, Peggie Pelosi, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig.
View institutional ownership trends
.

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX).

Company Calendar

Last Earnings
8/04/2026
Today
9/18/2026
Next Earnings (Estimated)
10/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Personal Care Products
Sub-Industry
Personal Care Products
Current Symbol
NYSE:USNA
CIK
896264
Employees
1,570
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($1.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
18.88
P/E Growth
1.61
Net Income
$10.76 million
Net Margins
-2.43%
Pretax Margin
0.28%
Return on Equity
3.41%
Return on Assets
2.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.66
Quick Ratio
1.84

Sales & Book Value

Annual Sales
$913.36 million
Price / Sales
0.29
Cash Flow
$4.03 per share
Price / Cash Flow
3.56
Book Value
$29.16 per share
Price / Book
0.49

Miscellaneous

Outstanding Shares
18,477,000
Free Float
18,325,000
Market Cap
$265.14 million
Optionable
Optionable
Beta
0.68

Social Links

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:USNA) was last updated on 9/18/2026 by MarketBeat.com Staff.
From Our Partners